1. Evolution of Sequence Type 4821 Clonal Complex Hyperinvasive and Quinolone-Resistant Meningococci
- Author
-
Odile B. Harrison, Xi Zhang, Min Chen, Mingliang Chen, Qinglan Guo, Zhiyan Bo, Martin C. J. Maiden, James E. Bray, Keith A. Jolley, Charlene M.C. Rodrigues, and Holly B. Bratcher
- Subjects
Microbiology (medical) ,Evolution of Sequence Type 4821 Clonal Complex Hyperinvasive and Quinolone-Resistant Meningococci ,China ,Epidemiology ,medicine.drug_class ,030231 tropical medicine ,Clone (cell biology) ,lcsh:Medicine ,Meningococcal Vaccines ,Biology ,Neisseria meningitidis ,Quinolones ,medicine.disease_cause ,Serogroup ,lcsh:Infectious and parasitic diseases ,03 medical and health sciences ,0302 clinical medicine ,Antibiotic resistance ,Data sequences ,medicine ,Serogroup c ,Humans ,lcsh:RC109-216 ,030212 general & internal medicine ,antimicrobial resistance ,bacteria ,genome ,Sequence (medicine) ,Original Research ,Strain (biology) ,Research ,phylogenetic analysis ,lcsh:R ,quinolone resistance ,Quinolone ,ST4821 clonal complex ,Virology ,recombination ,Europe ,Meningococcal Infections ,Infectious Diseases ,meningitis/encephalitis - Abstract
Expansion of quinolone-resistant Neisseria meningitidis clone ChinaCC4821-R1-C/B from sequence type (ST) 4821 clonal complex (CC4821) caused a serogroup shift from serogroup A to serogroup C invasive meningococcal disease (IMD) in China. To determine the relationship among globally distributed CC4821 meningococci, we analyzed whole-genome sequence data from 173 CC4821 meningococci isolated from 4 continents during 1972-2019. These meningococci clustered into 4 sublineages (1-4); sublineage 1 primarily comprised of IMD isolates (41/50, 82%). Most isolates from outside China (40/49, 81.6%) formed a distinct sublineage, the Europe-USA cluster, with the typical strain designation B:P1.17-6,23:F3-36:ST-3200(CC4821), harboring mutations in penicillin-binding protein 2. These data show that the quinolone-resistant clone ChinaCC4821-R1-C/B has expanded to other countries. The increasing distribution worldwide of serogroup B CC4821 raises the concern that CC4821 has the potential to cause a pandemic that would be challenging to control, despite indirect evidence that the Trumenba vaccine might afford some protection.
- Published
- 2021